ATE214273T1 - Verwendung von alicyclischen diaminen als immunomodulatoren - Google Patents

Verwendung von alicyclischen diaminen als immunomodulatoren

Info

Publication number
ATE214273T1
ATE214273T1 AT96927741T AT96927741T ATE214273T1 AT E214273 T1 ATE214273 T1 AT E214273T1 AT 96927741 T AT96927741 T AT 96927741T AT 96927741 T AT96927741 T AT 96927741T AT E214273 T1 ATE214273 T1 AT E214273T1
Authority
AT
Austria
Prior art keywords
benzyl
group
substituted
trihalomethyl
immunomodulators
Prior art date
Application number
AT96927741T
Other languages
English (en)
Inventor
Jean-Claude Maziere
Amar Achour
Jean-Charles Landureau
Daniel Zagury
Original Assignee
Neovacs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neovacs filed Critical Neovacs
Application granted granted Critical
Publication of ATE214273T1 publication Critical patent/ATE214273T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT96927741T 1995-08-03 1996-08-02 Verwendung von alicyclischen diaminen als immunomodulatoren ATE214273T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509459A FR2737409B1 (fr) 1995-08-03 1995-08-03 Nouvelles utilisations de diamines alticycliques
PCT/FR1996/001242 WO1997005859A2 (fr) 1995-08-03 1996-08-02 Utilisation de diamines alicycliques comme immunomodulateurs

Publications (1)

Publication Number Publication Date
ATE214273T1 true ATE214273T1 (de) 2002-03-15

Family

ID=9481683

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96927741T ATE214273T1 (de) 1995-08-03 1996-08-02 Verwendung von alicyclischen diaminen als immunomodulatoren

Country Status (13)

Country Link
US (1) US6228890B1 (de)
EP (1) EP0841909B1 (de)
JP (1) JP4037450B2 (de)
CN (1) CN1121214C (de)
AT (1) ATE214273T1 (de)
AU (1) AU6745096A (de)
BR (1) BR9610077A (de)
CA (1) CA2228689A1 (de)
DE (1) DE69619827T2 (de)
ES (1) ES2174094T3 (de)
FR (1) FR2737409B1 (de)
PT (1) PT841909E (de)
WO (1) WO1997005859A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004041161A2 (en) * 2002-10-30 2004-05-21 Merck & Co., Inc. Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
CN112691094B (zh) * 2019-10-22 2022-09-23 中国科学院分子细胞科学卓越创新中心 防治病毒的新型化合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1387971A (fr) * 1962-12-21 1965-02-05 Ayerst Mckenna & Harrison Nouvelles diamines alicycliques et leur procédé de préparation
US3244750A (en) * 1963-12-06 1966-04-05 American Home Prod Nu, nu'-disubstituted-aliphatic-bis-aminomethyl-cyclohexane derivatives
US3202712A (en) * 1963-02-05 1965-08-24 American Home Prod 1-cyclohexene-4-bis (omicron-chlorobenzylaminomethyl) and derivatives
US4060639A (en) * 1976-05-14 1977-11-29 Merck & Co., Inc. Broad spectrum antibacterial compositions containing tris-(hydroxymethyl)-aminoethane and dicycloaliphatic-alkyl polyamines
US5116823A (en) * 1990-02-27 1992-05-26 Roger Williams General Hospital Drug combinations containing AZT

Also Published As

Publication number Publication date
CA2228689A1 (fr) 1997-02-20
CN1193910A (zh) 1998-09-23
EP0841909B1 (de) 2002-03-13
WO1997005859A2 (fr) 1997-02-20
ES2174094T3 (es) 2002-11-01
FR2737409B1 (fr) 1997-10-24
BR9610077A (pt) 1999-03-02
CN1121214C (zh) 2003-09-17
EP0841909A2 (de) 1998-05-20
FR2737409A1 (fr) 1997-02-07
PT841909E (pt) 2002-08-30
WO1997005859A3 (fr) 1997-03-27
DE69619827T2 (de) 2002-11-07
DE69619827D1 (de) 2002-04-18
JP4037450B2 (ja) 2008-01-23
JPH11510803A (ja) 1999-09-21
AU6745096A (en) 1997-03-05
US6228890B1 (en) 2001-05-08

Similar Documents

Publication Publication Date Title
RU2495044C2 (ru) Ингибиторы активности протеинтирозинкиназы
EP0244115A3 (de) Phenylpiperazinderivate enthaltende anti-arrythmische Mittel
CY1107214T1 (el) Αγωνιστες και ανταγωνιστες υποδοχεων λυσοφωσφατιδικου οξεος (lpa) kai τροποι χρησης
ATE294577T1 (de) Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen
ATE433959T1 (de) Analoge von kokain
DE60234092D1 (de) Agonisten und antagonisten von sphingosin-1-phosphatrezeptoren
BR9612275A (pt) Composto composição farmacêutica processo para estimular a liberação do hormônio do crescimento pela pituitária e aumentar a taxa e a extensão do crescimento da produção do leite e lã ou para tratar doenças e uso de um composto
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
NO940737L (de)
FR2677982B1 (fr) Composes polyfluoroalkylthiopoly(ethylimidazolium), procede de preparation et leur utilisation comme agents biocides.
CA2110806A1 (en) 4-(1h-pyrrol-1-yl)imidazoles with angiotensin ii antagonist activity
ES8802420A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
BR9508901A (pt) Di-hidrobenzofurano e composto relacionados utilizáveis como agentes antiflamatórios
DE69613457T2 (de) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansäure derivate als tachykinin rezeptor antagonisten
BR0015364A (pt) 5-benzil-2,4-diaminopirimidinas substituìdas
EP0356029A3 (de) Insektizide Verbindungen
DK0526313T3 (da) Nye ureaderivater, deres fremstilling og terapeutiske anvendelse
EP0328203A3 (de) [5(6)-(1H-Azol-1-ylmethyl)Benzimidazol]-Karbamate
DE69619827T2 (de) Verwendung von alicyclischen diaminen als immunomodulatoren
HUP0000380A2 (hu) 2-[(4-Pirimidinil)-oxi-metil]-fenil-ecetsav-származékok és káros gombák és állati kártevők leküzdésére való alkalmazásuk
WO1998031704A3 (en) Tachykinin antagonists
ZA919069B (en) Pharmaceutical compositions
DK157131C (da) Carmamyloxybenzhydrolderivater, farmaceutisk praeparat samt en fremgangsmaade til fremstilling af dette
BR9813775A (pt) Uso de um composto, processo para o tratamento de uma condição de cefaléia vascular, e, composição farmacêutica adequada para uso no tratamento de uma condição de cefaléia vascular.
KR910014357A (ko) 신규 치환 β-피리미디닐옥시(티오)-및 β-트리아지닐옥시(티오) 시클로알칸카르복실산 유도체, 그의 제조 방법, 및 제초제, 살균제 및 식물 성장 조절제로서의 용도